HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S N Hay Selected Research

Heart Failure

9/2005Cardiogenic shock complicates successful treatment of refractory thrombotic thrombocytopenia purpura with rituximab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S N Hay Research Topics

Disease

2Thrombocytopenia (Thrombopenia)
09/2005 - 01/2004
1Cytopenia
09/2005
1Chest Pain (Chest Pains)
09/2005
1Cough
09/2005
1Drug Hypersensitivity (Drug Allergy)
09/2005
1Glycogen Storage Disease Type VI (Glycogenosis Type VI)
09/2005
1Heart Failure
09/2005
1Purpura
09/2005
1Respiratory Insufficiency (Respiratory Failure)
09/2005
1Cardiogenic Shock
09/2005
1Hypotension (Low Blood Pressure)
09/2005
1Lymphoma (Lymphomas)
09/2005
1Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
01/2005
1Papilledema
01/2004
1Renal Insufficiency (Renal Failure)
01/2004

Drug/Important Bio-Agent (IBA)

2thiamine triphosphorate (TTP)IBA
09/2005 - 01/2004
1Monoclonal AntibodiesIBA
09/2005
1Rituximab (Mabthera)FDA Link
09/2005
1CD20 AntigensIBA
09/2005
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2005

Therapy/Procedure

1Critical Care (Surgical Intensive Care)
09/2005
1Plasma Exchange
09/2005
1Therapeutics
01/2005